Literature DB >> 15322017

Contribution of the major secreted yops of Yersinia enterocolitica O:8 to pathogenicity in the mouse infection model.

Konrad Trülzsch1, Thorsten Sporleder, Emeka I Igwe, Holger Rüssmann, Jürgen Heesemann.   

Abstract

Pathogenic yersiniae (Yersinia pestis, Y. pseudotuberculosis, and Y. enterocolitica) harbor a 70-kb virulence plasmid (pYV) that encodes a type III secretion system and a set of at least six effector proteins (YopH, YopO, YopP, YopE, YopM, and YopT) that are injected into the host cell cytoplasm. Yops (Yersinia outer proteins) disturb the dynamics of the cytoskeleton, inhibit phagocytosis by macrophages, and downregulate the production of proinflammatory cytokines, which makes it possible for yersiniae to multiply extracellularly in lymphoid tissue. Y. enterocolitica serotype O:8 belongs to the highly mouse-pathogenic group of yersiniae in contrast to Y. enterocolitica serotype O:9. However, there has been no systematic study of the contribution of Yops to the pathogenicity of Y. enterocolitica O:8 in mice. We generated a set of yop gene deletion mutants of Y. enterocolitica O:8 by using the novel Red cloning procedure. We subsequently analyzed the contribution of yopH, -O, -P, -E, -M, -T, and -Q deletions to pathogenicity after oral and intravenous infection of mice. Here we showed for the first time that a DeltayopT deletion mutant colonizes mouse tissues to a greater extent than the parental strain. The DeltayopO, DeltayopP, and DeltayopE mutants were only slightly attenuated after oral infection since they were still able to colonize the spleen and liver and cause systemic infection. The DeltayopO mutant was lethal for mice, whereas DeltayopP and DeltayopE mutants were successfully eliminated from the spleen and liver 2 weeks after infection. In contrast the DeltayopH, DeltayopM, and DeltayopQ mutants were highly attenuated and not able to colonize the spleen and liver on any of the days tested. The DeltayopH, DeltayopO, DeltayopP, DeltayopE, DeltayopM, and DeltayopQ mutants had only modest defects in the colonization of the small intestine and Peyer's patches. The DeltayopE mutant was eliminated from the small intestine 3 weeks after infection, whereas the DeltayopH, DeltayopP, DeltayopM, and DeltayopQ mutants continued to colonize the small intestine at this time.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322017      PMCID: PMC517446          DOI: 10.1128/IAI.72.9.5227-5234.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  60 in total

1.  Yersinia pseudotuberculosis-induced calcium signaling in neutrophils is blocked by the virulence effector YopH.

Authors:  K Andersson; K E Magnusson; M Majeed; O Stendahl; M Fällman
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

Review 2.  The Yersinia Ysc-Yop 'type III' weaponry.

Authors:  Guy R Cornelis
Journal:  Nat Rev Mol Cell Biol       Date:  2002-10       Impact factor: 94.444

3.  The cytotoxin YopT of Yersinia enterocolitica induces modification and cellular redistribution of the small GTP-binding protein RhoA.

Authors:  R Zumbihl; M Aepfelbacher; A Andor; C A Jacobi; K Ruckdeschel; B Rouot; J Heesemann
Journal:  J Biol Chem       Date:  1999-10-08       Impact factor: 5.157

4.  An immunoglobulin superfamily-like domain unique to the Yersinia pseudotuberculosis invasin protein is required for stimulation of bacterial uptake via integrin receptors.

Authors:  P Dersch; R R Isberg
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

5.  Analysis of chaperone-dependent Yop secretion/translocation and effector function using a mini-virulence plasmid of Yersinia enterocolitica.

Authors:  Konrad Trülzsch; Andreas Roggenkamp; Martin Aepfelbacher; Gottfried Wilharm; Klaus Ruckdeschel; Jürgen Heesemann
Journal:  Int J Med Microbiol       Date:  2003-06       Impact factor: 3.473

6.  Virulence plasmid-encoded YopK is essential for Yersinia pseudotuberculosis to cause systemic infection in mice.

Authors:  A Holmström; R Rosqvist; H Wolf-Watz; A Forsberg
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

7.  Inhibition of the Fc receptor-mediated oxidative burst in macrophages by the Yersinia pseudotuberculosis tyrosine phosphatase.

Authors:  J B Bliska; D S Black
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

8.  Identification of an amino-terminal substrate-binding domain in the Yersinia tyrosine phosphatase that is required for efficient recognition of focal adhesion targets.

Authors:  D S Black; L G Montagna; S Zitsmann; J B Bliska
Journal:  Mol Microbiol       Date:  1998-09       Impact factor: 3.501

9.  Yersinia pseudotuberculosis inhibits Fc receptor-mediated phagocytosis in J774 cells.

Authors:  M Fällman; K Andersson; S Håkansson; K E Magnusson; O Stendahl; H Wolf-Watz
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

10.  Suppression of T and B lymphocyte activation by a Yersinia pseudotuberculosis virulence factor, yopH.

Authors:  T Yao; J Mecsas; J I Healy; S Falkow; Y Chien
Journal:  J Exp Med       Date:  1999-11-01       Impact factor: 14.307

View more
  80 in total

1.  Impact of the N-terminal secretor domain on YopD translocator function in Yersinia pseudotuberculosis type III secretion.

Authors:  Ayad A A Amer; Monika K Åhlund; Jeanette E Bröms; Åke Forsberg; Matthew S Francis
Journal:  J Bacteriol       Date:  2011-09-30       Impact factor: 3.490

2.  Eukaryotic initiation factor 2 (eIF2) signaling regulates proinflammatory cytokine expression and bacterial invasion.

Authors:  Niraj Shrestha; Wael Bahnan; David J Wiley; Glen Barber; Kenneth A Fields; Kurt Schesser
Journal:  J Biol Chem       Date:  2012-07-02       Impact factor: 5.157

3.  A protective epitope in type III effector YopE is a major CD8 T cell antigen during primary infection with Yersinia pseudotuberculosis.

Authors:  Yue Zhang; Patricio Mena; Galina Romanov; Jr-Shiuan Lin; Stephen T Smiley; James B Bliska
Journal:  Infect Immun       Date:  2011-11-07       Impact factor: 3.441

4.  Characterization of a novel porin involved in systemic Yersinia enterocolitica infection.

Authors:  Shirly Mildiner-Earley; Virginia L Miller
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

5.  The Yersinia enterocolitica effector YopP inhibits host cell signalling by inactivating the protein kinase TAK1 in the IL-1 signalling pathway.

Authors:  Axel Thiefes; Alexander Wolf; Anneke Doerrie; Guntram A Grassl; Kunihiro Matsumoto; Ingo Autenrieth; Erwin Bohn; Hiroaki Sakurai; Rainer Niedenthal; Klaus Resch; Michael Kracht
Journal:  EMBO Rep       Date:  2006-07-14       Impact factor: 8.807

6.  Expression of the Yersinia enterocolitica pYV-encoded type III secretion system is modulated by lipopolysaccharide O-antigen status.

Authors:  Camino Pérez-Gutiérrez; Catalina M Llompart; Mikael Skurnik; José A Bengoechea
Journal:  Infect Immun       Date:  2006-12-18       Impact factor: 3.441

7.  Yersinia effector YopO uses actin as bait to phosphorylate proteins that regulate actin polymerization.

Authors:  Wei Lin Lee; Jonathan M Grimes; Robert C Robinson
Journal:  Nat Struct Mol Biol       Date:  2015-02-09       Impact factor: 15.369

8.  Rapid engineering of bacterial reporter gene fusions by using Red recombination.

Authors:  Roman G Gerlach; Stefanie U Hölzer; Daniela Jäckel; Michael Hensel
Journal:  Appl Environ Microbiol       Date:  2007-05-18       Impact factor: 4.792

9.  Role of YopK in Yersinia pseudotuberculosis resistance against polymorphonuclear leukocyte defense.

Authors:  Sara E Thorslund; David Ermert; Anna Fahlgren; Saskia F Erttmann; Kristina Nilsson; Ava Hosseinzadeh; Constantin F Urban; Maria Fällman
Journal:  Infect Immun       Date:  2012-10-22       Impact factor: 3.441

10.  Intranasal inoculation of mice with Yersinia pseudotuberculosis causes a lethal lung infection that is dependent on Yersinia outer proteins and PhoP.

Authors:  Michael L Fisher; Cynthia Castillo; Joan Mecsas
Journal:  Infect Immun       Date:  2006-10-30       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.